^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:B Acute Lymphoblastic Leukemia
    Drug:Darzalex (daratumumab) (CD38 inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    04/04/2022
    Excerpt:
    REGIMENS FOR RELAPSED OR REFRACTORY Ph-NEGATIVE T-ALL...Other Recommended Regimens...Daratumumab